chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed arthritis of right hand, then left / Diagnosed Primary Arthritis; Fingers hurt, pain / plus pain in fingers; Tenderness in flesh below fingers / Tenderness of flesh continued; Could not grasp tools, etc; This is a spontaneous report received from a contactable reporter (consumer or other non-HCP). The reporter is the patient.   A 76-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2021 at 12:00 (Lot number: EN6201) at the age of 76 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Latex allergy" (unspecified if ongoing), notes: Known allergies: Latex and/or its adhesives and "Dermatitis contact" (unspecified if ongoing), notes: Known allergies: Latex and/or its adhesives. Concomitant medication included: OLIVE LEAF EXTRACT, stop date: 07Dec2021. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Anatomical Location: Left arm; Lot Number: EL9262; Administration Time: 12:00), administration date: 24Jan2021, when the patient was 76 years old, for COVID-19 immunisation.  The following information was reported: ARTHRITIS (non-serious) with onset 01Jul2021 at 12:00, outcome "unknown", described as "Developed arthritis of right hand, then left / Diagnosed Primary Arthritis"; PAIN IN EXTREMITY (non-serious) with onset 01Jul2021 at 12:00, outcome "recovered" (10Dec2021), described as "Fingers hurt, pain / plus pain in fingers"; PAIN (non-serious) with onset 01Jul2021 at 12:00, outcome "recovered" (10Dec2021), described as "Tenderness in flesh below fingers / Tenderness of flesh continued"; GRIP STRENGTH DECREASED (non-serious) with onset an unknown date in 2021, outcome "recovering", described as "Could not grasp tools, etc". The events "Developed arthritis of right hand, then left / Diagnosed Primary Arthritis", "Fingers hurt, pain / plus pain in fingers", "Tenderness in flesh below fingers / Tenderness of flesh continued" and "Could not grasp tools, etc" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of arthritis, pain in extremity, pain and grip strength decreased.  Additional information: Therapeutic measures included 6 weeks of physical therapy. Motion was restored, but relapsed within hours of therapy sessions. 07Dec2021, the patient stopped Olive leave capsules, 2/day, one with breakfast, 1 with supper. On 08Dec2021, pain abated, 09Dec2021, motion was partly restored, on 10Dec2021, 90% of motion was restored and the pain had gone. Olive leaf creates muscle pain and finger stiffness if there is preexisting auto-immune disease. Pfizer vaccine induced autoimmune disease reaction to spike protein blood vessel cells creates. The patient questioned how to stop the body from making more spike proteins. The patient did not receive any other vaccines within four weeks prior to the prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.
Increased bruising  with long healing time several months prior to having a fall October 25, 2021 with severe bruising in addition to what I thought was Sciatica, Went to  My primary Dr. who had me get a blood draw for labs, Platelets were at 11,000. Was sent to Hematology with Dr. who Dx'ed me with Acute ITP.
Onset was approx 11hrs p/adm of vax; sx included rash, pruritis, urticaria, heart palpatations; lasted approx 48hrs; tx DPH & Decadron;
Patient has developed a progressive neurological disorder first characterized by tingling in his extremities and urinary retention that has progressively worsened over the past several days. This could represent either a post viral myelitis or perhaps reaction to vaccinations (question yellow vaccine specifically).
dizzy; weak; left arm swelling; fever; chills; flu-like symptoms; 3 red spots on left arm; soreness left arm; This non-serious case was reported by a consumer via call center representative and described the occurrence of red spotty rash in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE (INFLUENZA SHOT) for prophylaxis.   Concurrent medical conditions included rheumatoid arthritis.   On 21-OCT-2023, the patient received the 1st dose of Shingrix (left arm) and INFLUENZA SHOT (right arm). In OCT-2023, an unknown time after receiving Shingrix, the patient experienced red spotty rash (Verbatim: 3 red spots on left arm), pain in arm (Verbatim: soreness left arm), dizziness (Verbatim: dizzy), weakness (Verbatim: weak), swelling arm (Verbatim: left arm swelling), fever (Verbatim: fever), chills (Verbatim: chills) and influenza-like symptoms (Verbatim: flu-like symptoms). The patient was treated with paracetamol (Tylenol). In OCT-2023, the outcome of the dizziness, weakness, swelling arm, fever, chills and influenza-like symptoms were resolved. The outcome of the red spotty rash and pain in arm were not resolved.   It was unknown if the reporter considered the red spotty rash, pain in arm, dizziness, weakness, swelling arm, fever, chills and influenza-like symptoms to be related to Shingrix.     It was unknown if the company considered the red spotty rash, pain in arm, dizziness, weakness, swelling arm, fever, chills and influenza-like symptoms to be related to Shingrix.   Additional Information: GSK receipt date: 24-Oct-2023 The caller stated that she got a dose of Shingrix and she also got the Flu shot in right arm on the same day.  She stated that in October 2023, hours later she had soreness and 3 red spots on left arm that had not resolved.  She also mentioned that she had swelling of left arm, fever and chills, flu-like symptoms, dizzy and weak.  She had been taking Tylenol. It was unknown if the reporter considered the red spotty rash, pain in arm, dizziness, weakness, swelling arm, fever, chills and influenza-like symptoms to be related to flu shot. The reporter consented to follow-up.
had the shots but continue to be effected by shingles/Suspected Vaccination Failure; effected by shingles; pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had the shots but continue to be effected by shingles/Suspected Vaccination Failure) (serious criteria GSK medically significant), shingles (Verbatim: effected by shingles) and pain (Verbatim: pain). The outcome of the vaccination failure was unknown and the outcome of the shingles was not resolved and the outcome of the pain was not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK receipt date: 23-MAR-2023 The case  was received from the patient via interactive digital media. The patient had them multiple times and could attest to the pain.  The patient stated that had the shots but he/she was one of those people who continue to be effected by shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Pt recv vax on 11/30/98; on 12/1/98 pt exp sore RA, fever (100.9), joints aching, nausea
This serious spontaneous case, initially received from other non-health professional (consumer) on 08-Jan-2018, concerns a elderly female patient of an unspecified age. The patient's current conditions included osteoporosis of spine, guttate psoriasis, small patches on skin and arthritic pain. On an unspecified date, the patient was administered with Influenza vaccine (dose, route of administration, batch number, expiry date, manufacturer, trade name and anatomical location: not reported). On an unspecified date, the patient was administered with non-company suspect product CONSENTYX solution (dose: 150 mg, once a month, subcutaneously) for an unknown indication and patient still had arthritic pain. On an unspecified date, after the vaccination, the patient experienced bad reaction to flu shot and had lost the use of her right hand. The outcome of the events was reported as recovered.
Diagnosed with Transverse Myelitis.  Have been seeing neurologist and am on Prednisone.  Have also had Prednisone infusions.
Within 3 minutes, developed ametallic taste in mouth, throat and tongue swelling, maintained swallow and breathing, heart rate increased vitals were ok.  Called ambulance.  Took bendryl.  Has had symptoms off/on few days after
Very large swelling one the arm where I received the shot and rash one week (exactly) after the first shot.
some rash near the injection site, under her armpit; This is a spontaneous report from a contactable consumer or other non hcp. A 69-years-old female patient received bnt162b2 (BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number: EL9262), via an unspecified route of administration, administered in Arm Left on 31Jan2021 09:10 (at the age of 69-years-old) as a second dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received bnt162b2 (BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number: EL3246) via unspecified route of administration, administered on 09Jan2021 16:00 (at the age of 69-years-old) as a first dose, single for covid-19 immunisation. After the first one, everything was okay. On 05Feb2021 the patient noticed some rash near the injection site, under her armpit. She had not treated the rash. The patient was recovered from the event in an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Initial report received on 04 February 2008 from a health care professional. On an "unknown" date, 10 children (demographics not provided, ages "unknown") received a dose of Fluzone (Lot number U2493AA). The route and sites of administration were not provided. At an unspecified amount of time later, all 10 children developed influenza; however no diagnostic testing was performed, or strain identified. It was "unknown" if any of the children had any illnesses or pre-existing medical conditions at the time of the vaccination. No other relevant medically significant information was provided.
Pt received 2nd Moderna COVID vaccine on 3/1/21. He experienced some aches, pains, and a stuffy nose for about 5 days. Pt used Tylenol as needed.
Vomiting; Woke up with blurry/hazy vision; Arm swelling; Nausea; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Woke up with blurry/hazy vision), PERIPHERAL SWELLING (Arm swelling), NAUSEA (Nausea), MYALGIA (Sore arm) and VOMITING (Vomiting) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced VISION BLURRED (Woke up with blurry/hazy vision), PERIPHERAL SWELLING (Arm swelling), NAUSEA (Nausea) and MYALGIA (Sore arm). On an unknown date, the patient experienced VOMITING (Vomiting). At the time of the report, VISION BLURRED (Woke up with blurry/hazy vision), PERIPHERAL SWELLING (Arm swelling), NAUSEA (Nausea), MYALGIA (Sore arm) and VOMITING (Vomiting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  Treatment information was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
LEFT ARM WAS REASONABLY SORE, FOR 2 DAYS. THEN MOVED UNDER LEFT ARM AND AROUND TO TOP OF LEFT SHOULDER AND IN COLLAR AREA. CAN'T MOVE ARM UP OR I DON'T HAVE ANY STRENGTH IN MY ARM. NO TREATMENT STARTED.
swollen cheeks, swollen tounge, blurred or double vision, headache, backache, weak shoulders, leg, heavy chest, SOB, shoulder, trembling in limbs
Patient received his flu shot at around 12:30 PM on 10/6/12. On 10/7/12 a 9:00AM he called to say that about 5-6 hours after getting the shot, he started to get dizzy. He did not seek medical attention and at the time he called on 10/7/12 he was feeling a little better.
Pain and swelling in the left arm started several hours after administration, as well as headache and lightheadedness. Patient reported little/minimal improvement of pain after taking TYLENOL, and felt faint due to intense sudden pain in the arm when her daughter accidentally grabbed her arm near injection site. Pain in the arm lasted 24-36 hours before beginning to improve. At time of reporting, patient still reports injection site is mildly tender.
Shot given and client states felt immediate intense sharp pain which continued until MD visit on 1/2/06. MD stated that bursa was possibly punctured from flu vaccination resulting in bursitis. Steroids given for 6 days in which pain subsided. Before medication client could not lift left arm above 45 degree angel. With medication client regained full ROM. Decreased strength which is slowly returning. On 1st day off med pain returned. Dr visit 1/10/06 and NASID given and MD stated to take indefinitely twice a day PRN for pain.
sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 69 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 16Mar2021 (Lot number: EN6205, Expiration Date: 30Jun2021) at the age of 69 years as dose 1, single and administered in arm right, administration date 14Apr2021 (Lot number: ER8733, Expiration Date: 31Jul2021) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Multiple sclerosis" (unspecified if ongoing), notes: Verbatim: MS. Concomitant medication(s) included: TYSABRI taken for multiple sclerosis (ongoing). Vaccination history included: Got flu shots way early this year, administration date: 21Sep2020, for Immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "sore arm".  Additional information: Physician was aware that she was going to get the shot, so she had correct time and stopped tysabri 2 weeks before she had to get it. Was right on target. The second dose was 2 weeks before going for the next stated that he was curious about the Pfizer Covid vaccine. He and his wife had gotten both of their shots. His wife had no side effects at all, just a sore arm where she got the shot. Caller was the original reporter and then handed phone to wife whom he was reporting on. Reporter details were updated to reflect that. Wife completed the report. The next morning when she woke up. It was a little like when you go to lift the elbow out, it just made the upper part of the arm a little sore. The second day, it was very light, then it was gone. Did not had any other problems and it was never red. It happened the same time with the first and the second. Time vaccination was given was around noon both times and event onset the next morning after both vaccines. No additional vaccines administered on same date of Pfizer suspect. The adverse event did not require to visit to Emergency Room/Physician's office. No prior vaccinations within 4 weeks. No relevant tests.  No follow-up attempts are possible. No further information is expected.
Vasovagal syncope Dizziness starting around 12am on 11/28, syncopal episode about 10-15 minutes later followed by nausea and dizziness for several hours. Fully resolved by 8am.
A vaccine administration error occurred. The patient had received their first dose of the COVID19 vaccine on 6/24/21 and received their second dose 14 days later on 7/8/21. The patient states that she felt "very sick" on Friday, 7/9 (e.g., "felt like a truck hit her" and "had symptoms of restless leg syndrome all over") and started only feeling remotely better on Sunday. She states that she has not felt 100% until today (7/15) but was still able to come back into work on Tuesday (she had to call off on Friday).
Patient presented to BWH ED on 4/11/21 with fatigue, headache, epistaxis in the setting of known covid infection. Pt was fully covid vaccinated. Pt was treated for covid and was discharged on 4/25/21.
Approximately 9 hours after injection, I was awakened with heart pounding in my chest and it felt fast but I did not check it. Watch did not show higher than 84 through the night but I could not sleep much due to the heart pounding. Arose for work at 6:15 and felt tired but the palpitations did not bother while standing. Temperature 98.8. about 90 minutes later, while at work, HR was 130-148, I was breathing deeply, otherwise okay. Chills started about 17 hours post-injection and temperature rose as high as 102.4 in the next 3 hours. HR lowered to about 110 about 16 hours post injection and did not get below 100 for another 12 hours. some coughing throughout this time, not productive. Heavy night sweats around 34 hours post injection. I had mild chills about 48 hours post injection, and fine since then. The palpitations were very uncomfortable but stopped once the HR lowered to about 110
This spontaneous report was received from a nurse refers to an unspecified patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unspecified date(s), the patient was administered an unspecified number of doses of M-M-R II. Concomitant medications were not reported. On an unknown date, the patient had titers drawn which exhibited a "negative immune response". Outcome of the event, action taken with the suspect product and causality was not reported. No product quality (PQC) was involved. Additional information is not expected since the reporter declined to provide any further information and no contacts details provided.
Neck developed a rash; This is a spontaneous report from a non-contactable consumer (patient). A 25-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot: EH9899) via an unspecified route of administration in right arm on 18Dec2020 20:30 single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. No allergies to medications, food, or other products reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced neck developed a rash on 20Dec2020 20:00 with outcome of unknown.    No follow-up attempts are possible. No further information is expected.
Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "82-year-old female with a past medical history significant for emphysema, pulmonary fibrosis, hyperlipidemia, left subclavian stenosis, GERD, migraines with a 20 pack-year smoking history who presented to the emergency department for increased cough and shortness of breath.  The patient states she is on 5-6 L baseline and 8 L on exertion.  She was found to be COVID positive in the emergency department.  Subsequent workup unremarkable CT pulmonary also unremarkable for PE.  Patient was treated with dexamethasone 6 mg as well as continuation of her home nebulizers.  The patient did receive cefepime for 1 course, this was subsequently discontinued as patient clinical status significantly improved.  After initial resuscitation in the emergency department, patient was almost back to baseline although she was admitted and watched for 2-3 continue days.  She was agreeable to going home on 2/11/23 as she was at baseline.  Patient was discharged at her previous baseline."
Clinic site that was a partner to said health department. Patient was given vaccine at facility on 3/29/2021 and then went back to site on 4/12/2021 for second dose. Vaccine was given after 14 days.
This spontaneous report as received from a registered pharmacist refers to a 69 years old female patient with no pertinent medical history, drug reaction or allergies. The patient was vaccinated subcutaneously in the left upper arm with dose of ZOSTAVAX (lot # H011430; exp date 12-SEP-2013) (dose and route not reported) on 16-NOV-2012. No other co-suspects were reported. There were no concomitant medications. The pharmacist reported that on an unknown date the patient was experiencing persistent pain near her left elbow (in 2012). The patient had self treated with MELOXICAM without any improvement. The patient sought medical attention by going by the pharmacy. No lab Diagnostic tests were performed. The outcome of persistent pain near her left elbow was reported as not recovered. The relatedness for persistent pain near her left elbow was not provided for ZOSTAVAX. Additional information has been requested.
Approx. 5 min after vaccine, mother was nursing infant. She not his head began shaking back and forth for a few seconds, then he was "out of it" for 1-2 min.
Developed respiratory distress with tachypnea and tachycardia. Evaluated in ER for respiratory status at about 03:00; received two neb treatments with albuterol. Admitted. On antibiotics clindamycin and Omnicef for possible pneumonia/infection. Respiratory status deteriorated and patient died. Discharge/Death Summary received on 11/23/2004 states pt experienced respiratory failure.
Client received Janssen COVID vaccine (LOT# 201A21A, exp: 09/01/2021) at approximately 1608. Co-Lead RN, noted client EMT walk over to client who was sitting in chair near vaccination table. Co-Lead RN approached EMT  and client. Per EMT, client alerted Vaccinator RPH that she was feeling lightheaded approximately 2 minutes after vaccination.  Client alert and oriented to date, time, place and event. Client notes she usually feels lightheaded, hot and flushed following blood draws and injections and notes this feels similar. Client's skins were pink, warm and dry. Client assisted to zero-gravity chair. At 1613, vital signs were taken in sitting position: BP: 132/77, HR: 50, and RR10.Client reports he last ate at approximately 1100 and notes she had a salad. Client denies any other symptoms of shortness of breath, chest pain, palpitations, numbness or tingling, itchiness, or nausea. Client denies allergies to medications/foods/environment. Client denies medical history or use of medications at this time. Vital signs were taken at 1626 in seated position: BP 126/92, HR: 61, RR:12. Co-Lead RN checked in with client at 1640, and client reported he is feeling well and does not have any complaints. Co-Lead RN provided client with ER precautions and advised client to follow up with PCP . Client verbalized understanding. Client left observation area at 1641 following 30 minute observation from onset of symptoms. Client walking with a steady gait.
after having mild heachache and fatigue the day of the vaccine, I woke at 2:00 am with searing gout pain in my right knee. First severe gout flare up in 18 months, I take allopurinol and get gout in both ankles, right knee and right big toe.  At approximately 3:30 am started feeling gout starting in the left ankle and took Indomethacin. Pain started to subside around 7 am, took another Indomethacin at 9 am. by noon started feeling close to normal with some fatigue. I cannot think of any of my gout triggers in the past week that could cause the attack. Did not see possible gout flare up as a side effect until I researched the web as my knee was on fire.